The News-Times on MSN
95 people with cancer sue CT's Boehringer Ingelheim over recalled drug Zantac
“[Boehringer Ingelheim] had little incentive to investigate the dangers in a product that was producing over $1 billion in ...
As the US Food and Drug Administration (FDA) continues to test ranitidine products, including the popular heartburn medicine Zantac, from multiple manufacturers for the carcinogen ...
The series of recalls of ranitidine (also known as Zantac) and nizatidine products grew longer with three US Food and Drug Administration (FDA) announcements on Tuesday and Wednesday. The 150 mg and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results